ASCVD Risk Estimator Plus and PREVENT calculator would have classified many patients as low risk 48 hours before MI. (HealthDay News) — Population-based cardiac screening tools fail to identify many ...
Please provide your email address to receive an email when new articles are posted on . Those with stage 1 hypertension had lower 10-year ASCVD risk when estimated using new PREVENT equations. Use of ...
Please provide your email address to receive an email when new articles are posted on . Artificial intelligence may predict 10-year heart disease risk from a single chest X-ray. For individuals with ...
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Just over a year ago the PREVENT calculator to ...
A risk calculator that incorporates established cardiovascular risk factors and additional cardiac biomarkers, such as high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type ...
Panel (A) shows classifications based on the ASCVD Risk Estimator Plus, where 45% (209/465) of patients would not have qualified for statin therapy or further testing. Panel (B) displays results from ...
The rules for statin and blood pressure (BP) medication initiation may need to be rewritten if a new and improved cardiovascular risk prediction tool is broadly implemented, research suggested. Use of ...
A retrospective study evaluated how risk- and symptom-based screening tools would have performed if applied 2 days before a patient's first heart attack. Many at-risk patients would have been missed ...
Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one, according to a new study led by Mount Sinai researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results